drugset / Trial / NCT02622763
Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment
RandomizedParallel-groupSingle-blindOther
Summary
Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment.
Timeline
- Start
- 2015-11
- Primary completion
- 2019-05-05
- Completion
- 2019-05-05
Outcome
Outcome not reported
Stopped (Enrollment): “low recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tolerogenic dendritic cells | Cell therapy | 1e+07 cells | Other |
| Subject | tolerogenic dendritic cells | Cell therapy | 1e+08 cells | Other |